NCT07048743View on ClinicalTrials.gov

Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Caregivers of Patients With Advanced Cancer

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 2, 2025

Primary Completion Date

December 2, 2027

Study Completion Date

December 2, 2027

Conditions

Caregiver Distress

Interventions

DRUG

Psilocybin

Single high-dose (25mg) capsule of psilocybin taken orally in the context of Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy

Trial Locations (1)

M5G 2C4

Toronto General Hospital, Toronto

All Listed Sponsors

lead

University Health Network, Toronto

OTHER